
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Setting expectations with oral selexipag: an expert consensus-based approach on best practices to initiate, dose, titrate, and manage side effects (SEs) in patients with pulmonary arterial hypertension (PAH).
Journal: Pulmonary pharmacology & therapeutics
Published: September 30, 2025
Riociguat in pulmonary arterial hypertension: Application of the 4-strata COMPERA 2.0 risk assessment tool in the PATENT studies.
Journal: Respiratory medicine
Published: August 02, 2024
Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension.
Journal: Journal of medical economics
Published: October 06, 2023
Impact of the COVID-19 pandemic on chronic disease management and patient reported outcomes in patients with pulmonary hypertension: The Pulmonary Hypertension Association Registry.
Journal: Pulmonary circulation
Published: January 30, 2023
Gaps in the Care of Pulmonary Hypertension: A Cross-Sectional Patient Simulation Study Among Practicing Cardiologists and Pulmonologists.
Journal: Journal of the American Heart Association
Published: January 11, 2023
Hispanic Ethnicity and Social Determinants of Health in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
Journal: Annals of the American Thoracic Society
Published: March 03, 2022
Safety of macitentan for the treatment of pulmonary hypertension: Real-world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS).
Journal: Pulmonary circulation
Published: January 28, 2022
Prediction of patient outcomes through social determinants of health: The Pulmonary Hypertension Association Registry (PHAR) evaluation.
Journal: Pulmonary circulation
Published: January 13, 2022
Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat.
Journal: Pulmonary circulation
Published: December 09, 2021
Obesity in Pulmonary Arterial Hypertension. The Pulmonary Hypertension Association Registry.
Journal: Annals of the American Thoracic Society
Published: October 21, 2020
Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
Journal: Annals of the American Thoracic Society
Published: October 16, 2020
Last Updated: 09/26/2026